In this Q&A, Jenna DiRito, PhD, COO and co-founder of Revalia Bio, discusses how earlier, human-relevant data is reshaping go/no-go decision-making in drug development and what a truly front-loaded workflow looks like in practice.
Jenna DiRito, PhD
Advertisement
COO and Co-Founder of Revalia Bio
Articles by Jenna DiRito, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Tailoring Your FSP Approach: Why One Model Doesn’t Fit Every Trial
2
ACT Brief: Multimodal AI Systems Architecture, Trust-Based Trial Recruitment, and Big Pharma AI Transformation
3
Beyond Eligibility: Making Trust and Behavioral Readiness Actionable in Clinical Trial Recruitment
4
AI-Enabled Systems Medicine: From Digital Promise to Clinical Operating Model
5